Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sun Pharmaceutical Industries Ltd. closed 10.79% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...

Sun Pharma has acquired Checkpoint Therapeutics for $355 million, enhancing its onco-dermatology portfolio with the ...

Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Chairman & Managing Director of Sun Pharma, said, "Combining UNLOXCYT, an FDAapproved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma, with Sun Pharma’s global presence means ...

The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...